The 12th Jeddah Update Conference in Endocrinology and Diabetes 2021

01-04 December, Online Conference, Jeddah

  • 00days
  • 00Hours
  • 00Minutes
  • 00Seconds

About The Event


Aims

- Present innovative strategies to increase awareness about how to properly treat type 2 and type 1 diabetes mellitus, prevent complications, and burden associated with diabetes.
- To improve the care of patients with common Endocrinological disorders.
- To improve the lives of those living with obesity, public healthcare, promoting the interdisciplinary nature of obesity management and education.


Conference objectives

- Explain current treatment trends in the management of patients with diabetes.
- Discuss novel new therapies and technology for thyroid and adrenal insufficiency disorders.
- To demonstrate proper medical management of obesity in adults and pediatrics populations.
- To illustrate awareness about negative impact of anabolic steroid abuse.

Target audience

MEDICINE
ENDOCRINOLOGY
DIABOTOLOGISTS
FAMILY MEDICINE PEDIATRICS
PHARMACY
PRIMARY HEALTH CARE
PREVENTIVE MEDICINENURSING
FAMILY & GENERAL PRACTICE
SURGEONSNUTRITION
MEDICAL BIOCHEMISTRY
HOSPITALISTS
OBS & GYNECOLOGIST

President

Dr. Afaf Alshammary


Scientific Committee Members

Dr. Nasser Aljuhani (chairman)
Dr. Tariq Nasser (Co-chairman)
Dr. Awad Alshahrani
Dr. Adnan Alshaikh

Event Details

14 CME
price 100 SR

Speakers

Here are some of our speakers

Melanie Davies

Prof. Melanie Davies

Hossein Gharib

Prof. Hossein Gharib

W. Timothy Garvey

Prof. W. Timothy Garvey

Richard Auchus

Prof. Richard Auchus

David Kendler

Prof. David Kendler

Raul Santos

Dr. Raul Santos

Afaf Alshammary

Opening Remarks

Dr. Afaf Alshammary

Session 1: Diabetes

Mohammad Alsofiani

New technology in diabetes management

Dr. Mohammad Alsofiani

Melanie Davies

Early onset type 2 diabetes

Prof. Melanie Davies

Nasser Aljuhani

Remission of type 2 diabetes mellitus

Dr. Nasser Aljuhani

Session 2: Thyroid

Hossein Gharib

Recurrent papillary thyroid carcinoma: how to diagnose & when to treat

Prof. Hossein Gharib

Ghada Alkhateeb

Drugs effect on thyroid

Prof. Ghada Alkhateeb

Hossein Gharib

Challenges in hyperthyroidism

Prof. Hossein Gharib

Session 3: Obesity

W. Timothy Garvey

New Obesity Medications and a New Paradigm for Treatment of Patients with Obesity

Prof. W. Timothy Garvey

Assim Alfadda

Post-bariatric surgery follow up

Prof. Assim Alfadda

Adnan Alshaikh

Pediatric obesity

Dr. Adnan Alshaikh

Session 4: Adrenal

Richard Auchus

Adrenal insufficiency

Prof. Richard Auchus

Dalal Almehmadi

Peri-operative management of patients undergoing pituitary surgery

Dr. Dalal Almehmadi

Richard Auchus

Primary aldosteronism

Prof. Richard Auchus

Session 5: Metabolic Bone Disorders

David Kendler

Sequencing anabolic and antiresorptive therapies

Prof. David Kendler

Richard Auchus

Anabolic androgenic steroid abuse

Prof. Richard Auchus

David Kendler

Imminent fracture risk

Prof. David Kendler

Session 6: Diabetes

Melanie Davies

100 years of insulin

Prof. Melanie Davies

Abbas Orabi

The role of microbiota in the evolution of DM2

Prof. Abbas Orabi

W. Timothy Garvey

Weight Loss Therapy as a Primary Therapeutic Intervention for DM2

Prof. W. Timothy Garvey

Session 7: Micellaneous

Angham Almutair

Is it type 1 or type 2 diabetes or MODY?

Dr. Angham Almutair

Bassam Abbas

Short stature in adolescents

Dr. Bassam Abbas

Amir Babiker

Endocrine complications of childhood cancer therapy

Dr. Amir Babiker

Session 8: Micellaneous

Raul Santos

Efficacy and safety of intensive LDL-C lowering for prevention of atherosclerotic cardiovascular disease.

Dr. Raul Santos

Hawazen Zarif

Update in glucose monitoring

Dr. Hawazen Zarif

Raul Santos

Novel therapies for severe dyslipidemias: from small molecules to biological agents

Dr. Raul Santos

Closing Remarks

Register

To register in this conference please select your plan

100 SAR

  • Interactive Sessions
  • Certificate of Attendance
  • 14 CME hours

* VAT. Included

Sponsors